Merrimack is applying its novel diagnostics and therapeutics in the clinic through the development of regimens for specific tumor types. These regimens couple diagnostic and therapeutic combinations that are targeted to improve patient outcomes. Click on the indications below to learn more about our regimens.
Merrimack currently has six oncology therapeutics in clinical development, multiple product candidates in pre-clinical development and an active Systems Biology- driven discovery effort.
Browse our library to explore published research papers, clincal data, conference presentations, and featured scientific news and events related to Merrimack..